International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19

[1]  I. Colmegna,et al.  Mesenchymal Stromal Cell-Derived Extracellular Vesicles , 2021, Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases.

[2]  D. Hermann,et al.  Mesenchymal Stromal Cell–Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils , 2020, Stroke.

[3]  I. Martin,et al.  Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential , 2020, Cytotherapy.

[4]  David Berlin,et al.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases , 2020, Translational Research.

[5]  J. Cuenca,et al.  Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19 , 2020, European Respiratory Journal.

[6]  J. Hagood,et al.  Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease , 2020, International journal of molecular sciences.

[7]  Taojiao Wang,et al.  Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.

[8]  Lei Liu,et al.  Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome , 2020, medRxiv.

[9]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[10]  M. Matthay,et al.  Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome. , 2020, American journal of respiratory cell and molecular biology.

[11]  Bo Diao,et al.  Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) , 2020, Frontiers in Immunology.

[12]  Chuan Qin,et al.  Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  A. Fernandez-Gonzalez,et al.  Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes. , 2019, JCI insight.

[14]  Jae W. Lee,et al.  Mesenchymal Stem Cell–Derived Extracellular Vesicles Decrease Lung Injury in Mice , 2019, The Journal of Immunology.

[15]  Q. Shu,et al.  Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury , 2019, Aging.

[16]  Tu-feng Chen,et al.  Exosomes Released by Bone Marrow Mesenchymal Stem Cells Attenuate Lung Injury Induced by Intestinal Ischemia Reperfusion via the TLR4/NF-κB Pathway , 2019, International journal of medical sciences.

[17]  J. Lötvall,et al.  Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10 , 2019, Stem Cell Research & Therapy.

[18]  C. Rathbone,et al.  The effects of cell type and culture condition on the procoagulant activity of human mesenchymal stromal cell-derived extracellular vesicles. , 2019, The journal of trauma and acute care surgery.

[19]  M. Gimona,et al.  Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. , 2019, Cytotherapy.

[20]  J. Laffey,et al.  Extracellular Vesicles from Interferon-&ggr;–primed Human Umbilical Cord Mesenchymal Stromal Cells Reduce Escherichia coli–induced Acute Lung Injury in Rats , 2019, Anesthesiology.

[21]  A. Hill,et al.  Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications , 2019, Journal of extracellular vesicles.

[22]  D. Hermann,et al.  Identification of the right cell sources for the production of therapeutically active extracellular vesicles in ischemic stroke. , 2019, Annals of translational medicine.

[23]  N. Y. Morozova,et al.  Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation , 2019, Cells.

[24]  M. Exline,et al.  Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. , 2019, The Lancet. Respiratory medicine.

[25]  S. Lim,et al.  Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway. , 2018, Cytotherapy.

[26]  T. Meulia,et al.  Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model , 2018, Stem Cell Research & Therapy.

[27]  M. Ericsson,et al.  Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation , 2018, American journal of respiratory and critical care medicine.

[28]  E. K. Cunningham,et al.  Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer , 2017, American journal of respiratory and critical care medicine.

[29]  J. Laffey,et al.  Fifty Years of Research in ARDS., Cell‐based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value , 2017, American journal of respiratory and critical care medicine.

[30]  Bernd Giebel,et al.  Concise Review: Developing Best‐Practice Models for the Therapeutic Use of Extracellular Vesicles , 2017, Stem cells translational medicine.

[31]  Michel Bremer,et al.  Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents , 2017, International journal of molecular sciences.

[32]  Mario Gimona,et al.  Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use , 2017, International journal of molecular sciences.

[33]  M. Gimona,et al.  A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles. , 2017, Cytotherapy.

[34]  Wael Nassar,et al.  Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases , 2016, Biomaterials Research.

[35]  P. Horn,et al.  Human mesenchymal and murine stromal cells support human lympho-myeloid progenitor expansion but not maintenance of multipotent haematopoietic stem and progenitor cells , 2016, Cell cycle.

[36]  D. Hermann,et al.  Enabling Technologies for Cell-Based Clinical Translation Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression , 2015 .

[37]  Qi Hao,et al.  Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. , 2015, American journal of respiratory and critical care medicine.

[38]  Andrew F. Hill,et al.  Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper , 2015, Journal of extracellular vesicles.

[39]  S. Lim,et al.  Mesenchymal stem cells secrete immunologically active exosomes. , 2014, Stem cells and development.

[40]  M. Epple,et al.  MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease , 2014, Leukemia.

[41]  M. Matthay,et al.  Human Mesenchymal Stem Cell Microvesicles for Treatment of Escherichia coli Endotoxin‐Induced Acute Lung Injury in Mice , 2014, Stem cells.

[42]  Gerard Pasterkamp,et al.  Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. , 2013, Stem cell research.

[43]  D. Phinney.  Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy , 2012, Journal of cellular biochemistry.

[44]  S. Lim,et al.  Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs , 2011, Journal of Translational Medicine.

[45]  L. Kanz,et al.  Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. , 2003, Haematologica.

[46]  D J Prockop,et al.  Donor variation in the growth properties and osteogenic potential of human marrow stromal cells , 1999, Journal of cellular biochemistry.